Exercise training is an important component of pulmonary rehabilitation, but it remains questionable how training intensity affects patient-centered outcomes. The aim of this study was to compare the effects of 2 aerobic training intensities on health-related quality of life (HRQOL), symptom control, and exercise tolerance in subjects with COPD.
METHODS:
Thirty-four subjects with mild to very severe COPD participated in an equivalence/non-inferiority randomized controlled trial with a parallel group blinded to 60 or 80% maximum work rate (Wmax) aerobic training intensity. The intervention was an out-patient pulmonary rehabilitation program conducted 3 times/week for 8 weeks. Outcomes were assessed with the St George Respiratory Questionnaire (primary outcome), Mahler's dyspnea index, London Chest Activity of Daily Living scale, 6-min walk test, and constant-load and incremental exercise tests.
RESULTS:
Subjects were randomly allocated to aerobic training intensity of 60% Wmax (group 1, n = 17) or 80% Wmax (group 2, n = 17). Although there were significant improvements in all outcomes for both groups, there were no between-group differences in mean change in the St George Respiratory Questionnaire (P = .31, 95% CI −12.0 to 3.9), Mahler's dyspnea index (P = .38), London Chest Activity of Daily Living scale (P = .92), 6-min walk test (P = .50, 95% CI 6.2–71.1), constant-load exercise test (P = .50), and incremental exercise test (P = .12). There was only one exercise-related adverse event of cardiac symptoms.
CONCLUSIONS:
Aerobic training intensity of at least 60% Wmax has a positive impact on COPD patient-centered outcomes, with no additional benefit of increasing intensity to 80% Wmax in HRQOL, symptom control, and exercise tolerance, challenging the present clinical attitude of rehabilitation professionals. (ClinicalTrials.gov registration NCT01944072.)
MathersC, FatDM. The global burden of disease: 2004 update. World Health Organization, Geneva.
2.
Respira. EFA: livro sobre a doença pulmonar obstrutiva crónica na Europa. In: FranchiM, editor. Lisbon, Portugal: Respira; Associação Portuguesa de Pessoas com DPOC e outras doenças respiratórias crónicas; 2010:132.
3.
ERS Task Force, PalangeP, WardSA, CarlsenKH, CasaburiR, GallagherCG, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J, 2007; 29(1):185–209.
4.
HillNS. Pulmonary rehabilitation. Proc Am Thorac Soc, 2006; 3(1):66–74.
5.
RodriguesF. [Limiting factors of exercise capacity in patients with COPD]. Rev Port Pneumol, 2004; 10(1):9–61. Article in Portuguese.
American Association of Cardiovascular and Pulmonary Rehabilitation. Guidelines for pulmonary rehabilitation programs, 4th edition. Champaign, Illinois: American Association of Cardiovascular and Pulmonary Rehabilitation; 2013.
8.
American Association for Respiratory Care. AARC clinical practice guideline: pulmonary rehabilitation. Respir Care, 2002; 37(5):617–625.
9.
RiesAL. ACCP/AACVPR evidence-based guidelines for pulmonary rehabilitation. Round 3: another step forward. J Cardiopulm Rehabil Prev, 2007; 27(4):233–236.
10.
NiciL, DonnerC, WoutersE, ZuwallackR, AmbrosinoN, BourbeauJ, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med, 2006; 173(12):1390–1413.
11.
FahyBF. Pulmonary rehabilitation for chronic obstructive pulmonary disease: a scientific and political agenda. Respir Care, 2004; 49(1):28–36; discussion 36-28.
12.
PiersonDJ. Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources. Respir Care, 2006; 51(3):277–288.
13.
GosselinkR, TroostersT, DecramerM. Exercise training in COPD patients: the basic questions. Eur Respir J, 1997; 10(12):2884–2891.
14.
SmidtN, de VetHC, BouterLM, DekkerJ, ArendzenJH, de BieRA, et al. Effectiveness of exercise therapy: a best-evidence summary of systematic reviews. Aust J Physiother, 2005; 51(2):71–85.
15.
MaltaisF, HershfieldE, StubbingD, WijkstraP, HatzoglouA, LoveridgeB, et al. Exercise training in patients with COPD. In: BourbeauJ, NaultD, BoryckiE, editors. Comprehensive management of chronic obstructive pulmonary disease. Hamilton, Ontario, Canada: BC Decker; 2002.
16.
RiesAL, BauldoffGS, CarlinBW, CasaburiR, EmeryCF, MahlerDA, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest, 2007; 131(5):4S–42S.
17.
TroostersT, DonnerC, ScholsA, DecramerM. Rehabilitation in chronic obstructive pulmonary disease. European Respiratory Monograph. Wakefield, United Kingdom: European Respiratory Society; 2006; 337–358.
18.
TroostersT, CasaburiR, GosselinkR, DecramerM. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2005; 172(1):19–38.
19.
SpruitMA, SinghSJ, GarveyC, ZuWallackR, NiciL, RochesterC, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med, 2013; 188(8):e13–e64.
20.
JonesPW, QuirkFH, BaveystockCM. The St George's respiratory questionnaire. Respir Med, 1991; 85(Suppl B):25–31; discussion 33-37.
21.
MahlerDA, WeinbergDH, WellsCK, FeinsteinAR. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest, 1984; 85(6):751–758.
22.
GarrodR, BestallJC, PaulEA, WedzichaJA, JonesPW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London chest activity of daily living scale (LCADL). Respir Med, 2000; 94(6):589–596.
23.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med, 2002; 166(1):111–117.
24.
CazzolaM. ATS/ERS Task Force: outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J, 2008; 31(2):416–469.
25.
FinchE, BrooksD, StratfordP, MayoN. Physical rehabilitation outcome measures: a guide to enhanced clinical decision making. Hamilton, Toronto, Ontario, Canada: Lippincott, Williams & Wilkins; 2002.
26.
WitekTJJr, MahlerDA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J, 2003; 21(2):267–272.
27.
HollandAE, HillCJ, RasekabaT, LeeA, NaughtonMT, McDonaldCF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil, 2010; 91(2):221–225.
28.
LavioletteL, BourbeauJ, BernardS, LacasseY, PepinV, BretonMJ, et al. Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax, 2008; 63(2):115–121.
29.
Puente-MaestuL, VillarF, de MiguelJ, StringerWW, SanzP, SanzML, et al. Clinical relevance of constant power exercise duration changes in COPD. Eur Respir J, 2009; 34(2):340–345.
30.
FerrerM, VillasanteC, AlonsoJ, SobradilloV, GabrielR, VilagutG, et al. Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J, 2002; 19(3):405–413.
31.
American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription, 9th edition. Baltimore, MD: Lippincot Williams & Wilkins; 2013.
32.
LacasseY, MartinS, LassersonTJ, GoldsteinRS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease: a Cochrane systematic review. Eura Medicophys, 2007; 43(4):475–485.
33.
PuhanMA, SchünemannHJ, FreyM, ScharplatzM, BachmannLM. How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction. Thorax, 2005; 60(5):367–375.
34.
BernardS, WhittomF, LeblancP, JobinJ, BelleauR, BérubéC, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1999; 159(3):896–901.
35.
PereiraAM, Santa-ClaraH, PereiraE, SimõesS, RemédiosI, CardosoJ, et al. Impact of combined exercise on chronic obstructive pulmonary patients' state of health. Rev Port Pneumol, 2010; 16(5):737–757.
36.
Montes de OcaM, TorresSH, GonzálezY, RomeroE, HernándezN, TálamoC. Changes in exercise tolerance, health related quality of life, and peripheral muscle characteristics of chronic obstructive pulmonary disease patients after 6 weeks' training. Arch Bronconeumol, 2005; 41(8):413–418.
37.
DouradoVZ, TanniSE, AntunesLC, PaivaSA, CampanaAO, RennoAC, GodoyI. Effect of three exercise programs on patients with chronic obstructive pulmonary disease. Braz J Med Biol Res, 2009; 42(3):263–271.
38.
ArnardóttirRH, SörensenS, RingqvistI, LarssonK. Two different training programmes for patients with COPD: a randomised study with 1-year follow-up. Respir Med, 2006; 100(1):130–139.
39.
FoglioK, BianchiL, BrulettiG, PortaR, VitaccaM, BalbiB, AmbrosinoN. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs. Respir Med, 2007; 101(9):1961–1970.
40.
NormandinEA, McCuskerC, ConnorsM, ValeF, GerardiD, ZuWallackRL. An evaluation of two approaches to exercise conditioning in pulmonary rehabilitation. Chest, 2002; 121(4):1085–1091.
41.
RochesterCL. Exercise training in chronic obstructive pulmonary disease. J Rehabil Res Dev, 2003; 40(5 Suppl 2):59–80.
42.
CasaburiR, PatessioA, IoliF, ZanaboniS, DonnerCF, WassermanK. Reductions in exercise lactic-acidosis and ventilation as a result of exercise training in patients with obstructive lung-disease. Am Rev Respir Dis, 1991; 143(1):9–18.
43.
MaltaisF, LeBlancP, JobinJ, BérubéC, BruneauJ, CarrierL, et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1997; 155(2):555–561.
44.
Puente-MaestuL, SánzML, SánzP, CubilloJM, MayolJ, CasaburiR. Comparison of effects of supervised versus self-monitored training programmes in patients with chronic obstructive pulmonary disease. Eur Respir J, 2000; 15(3):517–525.
45.
GimenezM, ServeraE, VergaraP, BachJR, PoluJM. Endurance training in patients with chronic obstructive pulmonary disease: a comparison of high versus moderate intensity. Arch Phys Med Rehabil, 2000; 81(1):102–109.
46.
HsiehMJ, LanCC, ChenNH, HuangCC, WuYK, ChoHY, TsaiYH. Effects of high-intensity exercise training in a pulmonary rehabilitation programme for patients with chronic obstructive pulmonary disease. Respirology, 2007; 12(3):381–388.
47.
ButcherSJ, JonesRL. The impact of exercise training intensity on change in physiological function in patients with chronic obstructive pulmonary disease. Sports Med, 2006; 36(4):307–325.
